<p>Susquehanna Fundamental Investments LLC 在最近向美國證券交易委員會（SEC）提交的文件中表示，在第四季度購買了 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的一項新股份。該基金購買了 45,860 股公司股票，價值約 616,000 美元。</p>
<p>其他大型投資者最近也對該公司的持股進行了調整。Tower Research Capital LLC TRC 在第四季度將其在 Oscar Health 的持股增加了 171.4%。Tower Research Capital LLC TRC 目前擁有 6,627 股公司股票，價值 89,000 美元，此前在上個季度又購買了 4,185 股。KBC Group NV 在第四季度將其在 Oscar Health 的持股增加了 56.1%。KBC Group NV 目前擁有 7,107 股公司股票，價值 96,000 美元，此前在此期間又購買了 2,555 股。ORG Wealth Partners LLC 在第四季度購買了價值約 100,000 美元的 Oscar Health 新頭寸。Alberta Investment Management Corp 在第四季度獲得了價值約 138,000 美元的 Oscar Health 新股份。最後，Virtu Financial LLC 在第四季度購買了價值約 140,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師評級調整</h2>
<p>另外，富國銀行（Wells Fargo &amp; Company）在 3 月 13 日的研究報告中將 Oscar Health 的股票評級從 “增持” 下調至 “持平”，並將公司的目標股價從 20.00 美元下調至 16.00 美元。兩位投資分析師對該股票給予了賣出評級，三位給予了持有評級，兩位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat 的數據，該公司的共識評級為 “持有”，共識目標價為 20.21 美元。</p>
<p><strong>查看我們最新的 OSCR 股票分析</strong></p>
<h2>Oscar Health 價格表現</h2>
<p>紐約證券交易所代碼 OSCR 的股票在週五開盤價為 13.19 美元。該公司的 50 日簡單移動平均線為 13.30 美元，200 日簡單移動平均線為 14.68 美元。公司的速動比率為 0.73，流動比率為 0.73，債務與股本比率為 0.26。該股票的市值為 33 億美元，市盈率為 -659.17，貝塔值為 1.75。Oscar Health, Inc. 的 52 周最低價為 11.20 美元，52 周最高價為 23.79 美元。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 2 月 4 日發佈了季度財報。該公司報告的每股收益為（0.62）美元，低於分析師的共識預期（0.55）美元，差距為（0.07）美元。Oscar Health 的淨利潤率為 0.28%，股本回報率為 2.28%。平均而言，股票分析師預測 Oscar Health, Inc. 在當前財政年度的每股收益將為 0.69 美元。</p>
<h2>Oscar Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Oscar Health, Inc. 在美國運營健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Oscar Health</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>Meta 在第一季度財報中表現出色 - 注意第二季度的關税影響</li>
<li>三隻國防股票將受益於軍事支出增加</li>
<li>亞馬遜財報：兩個值得關注的理由，和一個需要謹慎的理由</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>Palantir 財報：一個看漲信號和一個關注領域</li>
</ul>
<p><strong>想看看其他對沖基金持有的 OSCR 股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在考慮投資 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

OSCR

<p>Susquehanna Fundamental Investments LLC 在第四季度投資了 616,000 美元於 Oscar Health, Inc. (NYSE:OSCR)，購買了 45,860 股。其他投資者，包括 Tower Research Capital 和 KBC Group，也增加了他們的持股。目前，75.70% 的股票由機構投資者持有。分析師對該股票的評級不一，普遍評級為 “持有”，目標價格為 20.21 美元。Oscar Health 的股票開盤價為 13.19 美元，市值為 33 億美元，最近的每股收益為（0.62 美元）</p>

<p>Susquehanna Fundamental Investments LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 45,860 shares of the company's stock, valued at approximately $616,000.</p>
<div class="lb-trans"><p>Susquehanna Fundamental Investments LLC 在最近向美國證券交易委員會（SEC）提交的文件中表示，在第四季度購買了 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的一項新股份。該基金購買了 45,860 股公司股票，價值約 616,000 美元。</p>
</div><p>Other large investors have also recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its holdings in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock valued at $89,000 after buying an additional 4,185 shares in the last quarter. KBC Group NV raised its holdings in Oscar Health by 56.1% in the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares during the period. ORG Wealth Partners LLC purchased a new position in Oscar Health during the fourth quarter worth approximately $100,000. Alberta Investment Management Corp acquired a new stake in Oscar Health in the fourth quarter valued at approximately $138,000. Finally, Virtu Financial LLC purchased a new stake in shares of Oscar Health in the fourth quarter valued at approximately $140,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他大型投資者最近也對該公司的持股進行了調整。Tower Research Capital LLC TRC 在第四季度將其在 Oscar Health 的持股增加了 171.4%。Tower Research Capital LLC TRC 目前擁有 6,627 股公司股票，價值 89,000 美元，此前在上個季度又購買了 4,185 股。KBC Group NV 在第四季度將其在 Oscar Health 的持股增加了 56.1%。KBC Group NV 目前擁有 7,107 股公司股票，價值 96,000 美元，此前在此期間又購買了 2,555 股。ORG Wealth Partners LLC 在第四季度購買了價值約 100,000 美元的 Oscar Health 新頭寸。Alberta Investment Management Corp 在第四季度獲得了價值約 138,000 美元的 Oscar Health 新股份。最後，Virtu Financial LLC 在第四季度購買了價值約 140,000 美元的 Oscar Health 新股份。目前，75.70% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>Separately, Wells Fargo &amp; Company cut shares of Oscar Health from an &#34;overweight&#34; rating to an &#34;equal weight&#34; rating and dropped their price target for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and a consensus target price of $20.21.</p>
<div class="lb-trans"><p>另外，富國銀行（Wells Fargo &amp; Company）在 3 月 13 日的研究報告中將 Oscar Health 的股票評級從 “增持” 下調至 “持平”，並將公司的目標股價從 20.00 美元下調至 16.00 美元。兩位投資分析師對該股票給予了賣出評級，三位給予了持有評級，兩位給予了買入評級，一位給予了強烈買入評級。根據 MarketBeat 的數據，該公司的共識評級為 “持有”，共識目標價為 20.21 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 OSCR 股票分析</strong></p>
</div><h2>Oscar Health Price Performance</h2>
<div class="lb-trans"><h2>Oscar Health 價格表現</h2>
</div><p>Shares of NYSE OSCR opened at $13.19 on Friday. The firm has a 50-day simple moving average of $13.30 and a 200-day simple moving average of $14.68. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of -659.17 and a beta of 1.75. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79.</p>
<div class="lb-trans"><p>紐約證券交易所代碼 OSCR 的股票在週五開盤價為 13.19 美元。該公司的 50 日簡單移動平均線為 13.30 美元，200 日簡單移動平均線為 14.68 美元。公司的速動比率為 0.73，流動比率為 0.73，債務與股本比率為 0.26。該股票的市值為 33 億美元，市盈率為 -659.17，貝塔值為 1.75。Oscar Health, Inc. 的 52 周最低價為 11.20 美元，52 周最高價為 23.79 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 2 月 4 日發佈了季度財報。該公司報告的每股收益為（0.62）美元，低於分析師的共識預期（0.55）美元，差距為（0.07）美元。Oscar Health 的淨利潤率為 0.28%，股本回報率為 2.28%。平均而言，股票分析師預測 Oscar Health, Inc. 在當前財政年度的每股收益將為 0.69 美元。</p>
</div><h2>Oscar Health Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc. 在美國運營健康保險。該公司在個人和小型團體市場提供健康計劃，以及 +Oscar，一個技術驅動的平台，幫助提供者和支付方直接實現向基於價值的護理轉型。它還提供再保險產品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2</li>
<li>3 Defense Stocks Set to Benefit From Increased Military Spending</li>
<li>Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>Palantir Earnings: 1 Bullish Signal and 1 Area of Concern</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Oscar Health</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>Meta 在第一季度財報中表現出色 - 注意第二季度的關税影響</li>
<li>三隻國防股票將受益於軍事支出增加</li>
<li>亞馬遜財報：兩個值得關注的理由，和一個需要謹慎的理由</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>Palantir 財報：一個看漲信號和一個關注領域</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 OSCR 股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮投資 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Susquehanna Fundamental Investments LLC 向 Oscar Health, Inc.（紐約證券交易所代碼：OSCR）投資了 616,000 美元